Physician
Joshua P June DO
Joshua P June DO was paid $7.02M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is J0490, Injection, belimumab, 10 mg — 50% of everything it billed.
33Billing provider infoJOSHUA P JUNE DO
LANSING, MI 48911
LANSING, MI 48911
33aNPI1548717580assigned 09/07/2016
33bProvider typeRheumatology Physician
28Total paid$7.02M
24GClaims34,459
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Michigan
Rank by total paid#1 of 39
Median peer was paid$37K
This provider vs. median192×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,368 | $423K | |
| 2019 | 3,769 | $537K | |
| 2020 | 4,164 | $797K | |
| 2021 | 4,410 | $984K | |
| 2022 | 5,907 | $1.37M | |
| 2023 | 6,868 | $1.68M | |
| 2024incomplete | 4,973 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0490 | Injection, belimumab, 10 mg | 50% | 3,506 | 1,367 | $3.53M |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 27% | 922 | 796 | $1.89M |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8.6% | 317 | 271 | $606K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.9% | 9,453 | 8,942 | $484K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 4,169 | 3,851 | $155K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.8% | 2,849 | 2,508 | $125K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | <1% | 30 | 25 | $47K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 551 | 542 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,533 | 1,423 | $35K |
| 96415 | <1% | 938 | 787 | $13K | |
| 99205 | Prolong outpt/office vis | <1% | 102 | 102 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,374 | 2,156 | $13K |
20 more codes
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,474 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,359 | $8K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,719 | $7K |
| 98927 | <1% | 208 | $6K | |
| 90674 | <1% | 203 | $5K | |
| 90670 | <1% | 16 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 817 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 227 | $3K |
| G0008 | Administration of influenza virus vaccine | <1% | 191 | $2K |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | <1% | 182 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 472 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 70 | $631.40 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 232 | $630.70 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 105 | $572.01 |
| 90756 | <1% | 23 | $533.20 | |
| 90661 | <1% | 14 | $479.05 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 25 | $147.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 178 | $92.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 188 | $36.32 |
| 90653 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJUNE, JOSHUA (DIRECTOR)